DelveInsight launched a new report on Germany Healthcare Outlook Report 2022.
DelveInsight’s “Germany Healthcare Outlook Report, 2022” report provides comprehensive insights about healthcare scenarios, regulatory policies, and reimbursement landscape in Germany. The report also identifies key trends in the healthcare market and provides insights into the demographic and healthcare infrastructure of the country. Along with this the report also provides a brief look into the trends and segmentation of the pharmaceutical and medical devices market of Germany.
Request for sample pages of the report: https://www.delveinsight.com/sample-request/germany-healthcare-outlook-report
About GERMANY Healthcare Outlook Report 2022
Germany officially the Federal Republic of Germany is a country in Central and Western Europe with 83.2 million people, distributed on a territory of 357,022 square kilometers. In 2019, GDP growth for Germany was 0.6 %. Germany has a universal multi-payer health care system. It encompasses both statutory health insurance for people who earn less than a certain salary, as well as private health insurance for those who earn more and choose to purchase their own. Health insurance is provided by two subsystems: statutory health insurance (SHI), consisting of competing, not-for-profit, nongovernmental health insurance plans known as sickness funds; and private health insurance. Long-term care services are covered separately under Germany’s mandatory, statutory long-term care insurance (LTCI). Unlike those in many other countries, sickness funds and private health insurers, as well as long-term care insurers, use the same providers. In other words, hospitals and physicians treat all patients regardless of whether they have SHI or private insurance.
Germany Industry Overview Chapter
Pharmaceutical
The German pharmaceutical market is the largest in Europe and the fourth largest in the world. 1170 pharmaceutical and biotechnology companies with more than 128,000 workers (2015) operate in Germany. In addition to globally successful enterprises, the industry composed of more than 800 medium-sized businesses and young biotech companies. German companies invest $6.5 billion (2016) annually in research and development. Within Europe, Germany is the leading market for non-prescription medicines products.
Medical Device
The German medical device market is the largest in Europe and the third largest in the world. It was valued at $26 billion in 2014 and continues to grow despite a sluggish European economy. Germany has become one of the world’s most important countries for clinical studies. Germany is the leader in industry-initiated clinical studies in Europe and second worldwide. The dense network of universities and faculties as well as a variety of research institutions not affiliated to universities speak in favor of Germany as a business location.
Apart from this the report covers some latest information on COVID 19 update and future of healthcare technology in Germany.
Key Players
- Fresenius AG
- Bayer AG
- Evotec AG
- Boehringer Ingelheim
- Merck KGaA
- Helios Kliniken GmbH
- Sandoz International GmbH
- Symrise AG
- Alexianer GmbH
- TÜV NORD Group
Click here and get access to free sample pages of the Germany Healthcare Outlook report.
Table of Contents:
1. Key Insights
2. Germany at a Glance
3. Executive Summary
4. Assessment
5. Market Access
6. Germany PESTLE Analysis
7. Driver and Barriers
8. Appendix
9. References
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/